×
AllNewsVideosImages Maps Shopping Books
Search tools
Past year
  • Any time
  • Past hour
  • Past 24 hours
  • Past week
  • Past month
  • Past year
All results
Clear

Therapeutic Applications of Nanomedicine: Recent ... - MDPI

www.mdpi.com › ...
Apr 30, 2024 · A phase-2 trial combining oral temozolomide with intravenous SGT-53 (P53 gene therapy) sponsored by SynerGene Therapeutics is being conducted to treat recurrent ...

PEGylated therapeutics in the clinic - PMC - NCBI

www.ncbi.nlm.nih.gov › PMC10771556
Sep 22, 2023 · Advanced Search · User Guide · Journal List · Bioeng ... SynerGene Therapeutics, Inc. Not yet recruting ... Yang Q, Jacobs TM, McCallen JD, et al. Analysis of pre ...

Smart nanoparticles for cancer therapy - PMC - NCBI

www.ncbi.nlm.nih.gov › PMC10622502
Nov 3, 2023 · Smart nanoparticles, which can respond to biological cues or be guided by them, are emerging as a promising drug delivery platform for precise cancer ...

Tumor and Peritoneum-Associated Macrophage Gene Signature as a ...

www.mdpi.com › ...
Apr 8, 2024 · Highly Immunosuppressive M2TS Is Associated with Negative Prognostic Clinical Factors. We analyzed 341 primary GC samples in the TCGA stomach cancer database.
People also search for
PEGylated drugs list
PEGylated therapeutics
In order to show you the most relevant results, we have omitted some entries very similar to the 4 already displayed. If you like, you can repeat the search with the omitted results included.